(Reuters) - North Korea is expected to receive nearly two million doses of the AstraZeneca-Oxford COVID-19 vaccine by the first half of this year, said agencies leading the COVAX vaccine-sharing programme.
The COVAX Facility will distribute 1.992 million doses of the vaccine produced by the Serum Institute of India, according to the COVAX interim distribution report on Wednesday. bit.ly/3rfMnh2
COVAX, which secures vaccines for poor countries, is co-led by the GAVI alliance, the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations and the U.N. Children’s Fund.
North Korea has not reported a single case of COVID-19 till date, according to the WHO website.
Reporting by Anirudh Saligrama and Rama Venkat in Bengaluru; Editing by Kim Coghill and Tom Hogue
Our Standards: The Thomson Reuters Trust Principles.